Clinical experience revealed that a fraction of patients treated with TNF antagonists developed (increased) anti-dsDNA antibodies, in some cases with a concomitant lupus-like syndrome [28,29]. This evidence concerns the gene TNF and drug-induced lupus erythematosus.